U.S. Industrial REITs Stock News

Wondering if Aptiv's current share price reflects its true worth, or if the recent swings are masking a clearer story about value. Aptiv closed at US$57.11, with returns of a 5.2% decline over 7 days, a 1.9% decline over 30 days, a 27.2% decline year to date, but a 10.3% gain over the past year, which can leave the stock looking quite different depending on the time frame you focus on. Those mixed returns sit against a backdrop of ongoing attention on Aptiv as an auto components supplier, as...

Geospace Technologies (GEOS) opened Q1 2026 with revenue of US$25.6 million and a basic EPS loss of US$0.76, alongside a trailing twelve month basic EPS loss of US$2.17 on revenue of US$99.2 million. Over recent quarters the company has reported revenue between US$18.0 million and US$37.2 million, while EPS has ranged from a profit of US$0.66 per share in Q1 2025 to several loss-making quarters since. For investors, that mix of fluctuating topline and persistent losses keeps the attention on...

Janus Henderson Group (JHG) closed out FY 2025 with fourth quarter revenue of US$1.1 billion and basic EPS of US$2.64, capping a trailing twelve month net income of US$798.3 million on basic EPS of US$5.25. Over the past year, total revenue has moved from US$2.5 billion on trailing basic EPS of US$2.57 to US$3.1 billion on trailing basic EPS of US$5.25, alongside an improvement in net profit margin from 16.1% to 25.8%. This puts earnings quality front and center for investors assessing the...

If you are wondering whether Par Pacific Holdings at US$62.25 is still attractively priced after a strong run, the next sections will walk through what the current market price may be implying about the stock. The share price has pulled back with a 5.2% decline over the last week and a 3.7% decline over the last month, even though the year to date return stands at 73.8% and the 1 year return at 255.1%. Recent news coverage has focused on Par Pacific Holdings as an oil and gas refiner and...

Assertio Holdings (ASRT) closed out FY 2025 with Q4 revenue of US$13.5 million and basic EPS of a US$1.86 loss, alongside a trailing twelve month revenue base of US$118.7 million and basic EPS of a US$4.74 loss. Over the past year, quarterly revenue has moved between US$26.5 million and US$49.5 million, while quarterly basic EPS has ranged from a US$2.56 loss to US$1.78, leaving investors focused on how these shifts are feeding through to underlying margins. See our full analysis for Assertio...

SIFCO Industries (SIF) opened Q1 2026 with total revenue of US$24.0 million and net income of US$1.8 million, translating to basic EPS of US$0.29 for the quarter. The company has seen quarterly revenue move from US$21.7 million in Q4 2024 to US$20.9 million in Q1 2025 and then to US$24.0 million in Q1 2026. Basic EPS shifted from a loss of US$0.25 in Q4 2024 and US$0.40 in Q1 2025 to a profit of US$0.29 in the latest period. This sets up an earnings season in which investors are likely to...

Enerpac Tool Group Corp. recently expanded its leadership team, promoting Phil Jefferson to Executive Vice President and Chief Commercial Officer with added oversight of the Asia Pacific region, and elevating Mart Hinnen to Executive Vice President of Innovation & Heavy Industrial Technologies with responsibility for the Heavy Lifting Technology and DTA businesses. The promotions consolidate global commercial and innovation leadership under two experienced insiders, potentially sharpening...

Token Cat (TC) has just posted its H1 2025 numbers, with revenue of C¥19.8 million and a net income loss of C¥0.7 million, translating to basic EPS of C¥5.74 loss per share, while trailing 12 month figures show revenue of C¥36.6 million and a net loss of C¥148.0 million, or C¥1,200.49 loss per share. Over recent half year periods the company has seen revenue move from C¥32.3 million in H1 2024 to C¥16.9 million in H2 2024 and then to C¥19.8 million in H1 2025. Over the same periods, EPS...

Afya (NasdaqGS:AFYA) reports revenue and EBITDA growth, highlighting resilient financial performance in its latest earnings update. The Medical Practice Solutions segment faces pressure from declining active payers and stronger competition from AI driven tools. These developments point to a mixed picture for Afya, with solid headline results and emerging challenges beneath the surface. Afya operates across medical education and healthcare services in Brazil, and its latest report underlines...

For readers considering whether Sprouts Farmers Market at around US$80.99 still represents good value, or whether the key part of the move has already occurred, this article outlines what the current price may be implying. The stock has been choppy recently, with a 1% slip over the last week, a 5% gain over the last month, a modest 0.4% return year to date, and a 48.8% decline over the past year. This sits alongside a 120.3% return over three years and 212.8% over five years. These moves...

If you are wondering whether Arrowhead Pharmaceuticals at around US$77.95 is still offering value or has already run too far, this breakdown is designed to help you frame that question clearly. The stock has returned 6.1% over the past week, 27.4% over the last 30 days, 15.0% year to date, and 488.3% over the past year, which naturally raises questions about how much of the story is already priced in. Recent coverage has focused on Arrowhead Pharmaceuticals' progress in RNA interference...

In late April 2026, CVR Energy, Inc. reported first quarter 2026 results showing sales of US$1,980 million, a larger net loss of US$192 million, higher refining throughput, a US$0.10 per share cash dividend, and new production guidance for the second quarter. This combination of stronger volumes but wider losses, alongside the decision to pay a dividend, gives investors fresh insight into the company’s balance between growth, profitability, and cash returns. We’ll now examine how higher...

If you are wondering whether Capital Southwest stock still offers value at its current price, this article walks through the numbers so you can judge how the valuation stacks up for yourself. With the share price at US$23.99, recent returns of 6.3% over 30 days, 7.6% year to date and 35.5% over the past year put a clear spotlight on how investors are currently pricing the stock and what that might mean for future risk and reward. Those returns sit alongside a longer record, including 89.7%...

SkyWater Technology, Inc. has released its first‑quarter 2026 results, reporting sales of US$160.69 million versus US$61.3 million a year earlier, alongside a net loss of US$12.31 million and basic and diluted loss per share from continuing operations of US$0.25, both larger than the prior year. The combination of rapidly higher revenue and a wider loss profile highlights how SkyWater’s growth investments are still weighing on profitability, a pattern that investors may re‑evaluate against...

Axcelis Technologies reported first-quarter 2026 revenue of US$198.96 million, slightly above the prior year, while net income and earnings per share declined meaningfully year over year. Alongside guiding to higher second-quarter revenue and earnings, Axcelis highlighted momentum in memory and silicon carbide markets and showcased its MUSIC™ implant technology at an industry conference, underlining its focus on equipment innovation. Next, we’ll examine how this combination of...

If you are trying to work out whether LyondellBasell Industries' current share price reflects its underlying value, the recent moves in the stock give you plenty to think about. The stock closed at US$71.51, with a 4.1% decline over the past week and a 10.9% decline over the past month, yet it has returned 61.1% year to date and 36.5% over the last year. Recent coverage around LyondellBasell has focused on its position within the broader chemicals sector and how investors are weighing...

In the first quarter of 2026, Allegion reported sales of US$1,033.6 million, up from US$941.9 million a year earlier, while net income declined to US$138.1 million and diluted EPS from continuing operations eased to US$1.59. The company attributed the profit pressure to margin impacts from ERP-related production issues in its international business, even as it raised full-year 2026 revenue growth guidance to 6%–8% and projected full-year EPS of US$7.95–US$8.15. Next, we will examine how...

Navan (NasdaqGS:NAVN) has secured Criteo and Schindler as new enterprise clients for its AI-powered corporate travel platform. The agreements cover multi country travel programs and use Navan’s unified system for booking, policy compliance, and traveler support. Both clients are using Navan’s tools for operational efficiency, sustainability tracking, and user satisfaction across their global workforces. For investors watching corporate travel and expense software, Navan sits at the...

Legence (NasdaqGS:LGN) reported strong quarterly results, supported by organic growth across the business. The Installation & Maintenance segment delivered major outperformance within the period. Recent acquisitions were integrated into the business, contributing to current operations. Management raised 2026 guidance, signaling higher internal expectations for future performance. Legence, listed as NasdaqGS:LGN, focuses on installation and maintenance services, an area that can be closely...

Wondering if Quanta Services at around US$750 per share still offers value, or if most of the opportunity is already priced in. The stock has returned 3.2% over the last week, 35.1% over the last month, 70.7% year to date and 130.3% over the past year, with a very large 5 year return close to 7x. These moves are drawing fresh attention to Quanta Services as investors reassess what they are willing to pay for infrastructure and capital projects exposure. Recent coverage has focused on how the...

Wondering whether FTAI Aviation stock still offers value at its current price, or if most of the opportunity is already reflected in the share price. The stock last closed at US$272.54, with returns of 9.2% over 7 days, 13.1% over 30 days, 29.6% year to date, 149.9% over 1 year, and a very large 3 year and 5 year return. Recent coverage has focused on how this rapid share price performance has put more attention on what investors are paying for each dollar of future cash flow and asset...

Wondering if Revolution Medicines at around US$142.51 is still offering value after its strong run, or if you are late to the story? This article focuses squarely on what the current price could mean for you as a shareholder. The stock has seen a 1.1% decline over the last 7 days, but that comes after strong gains of 48.0% over 30 days, 80.3% year to date, 240.0% over 1 year and a very large 3 year return of 456.2% and 5 year return of 363.6%. Recent headlines around Revolution Medicines...

Wondering if CubeSmart at US$40.25 is offering good value right now, or if the easy gains are already behind it. The stock has been relatively steady over the last year with a 0.1% return, but the 8.1% return over 30 days and 13.7% return year to date show that sentiment around the shares has shifted recently. Recent trading moves have picked up as investors reassess listed real estate and storage focused stocks more broadly, with CubeSmart part of that conversation. This has put more...

A10 Networks, Inc. has already reported first-quarter 2026 results, with revenue of US$75.0 million and net income of US$12.03 million, while its board approved a US$0.06 quarterly dividend and the company continued share repurchases under its existing buyback program. The company also reiterated its full-year 2026 outlook for revenue and earnings growth, underscoring management confidence in ongoing demand for its networking and security solutions. We’ll now examine how A10’s reaffirmed...